Astellas’ eyes filings for menopause drug fezolinetant after ph3 win
FDA clears Myovant’s relugolix for uterine fibroids, setting up AbbVie clash
Pfizer/Myovant take relugolix contraceptive combination pill into phase 3
What can we learn from women’s health data?
VivoPlex raises funding to develop intra-uterine sensor
Hormonal drug shortages in UK ‘harming women’, say doctors
Merck & Co spin off could start a trend in big pharma
Merck to spin old drugs into ‘NewCo’ focused on generics, women’s health